X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4413) 4413
Publication (493) 493
Book Chapter (94) 94
Book Review (85) 85
Government Document (17) 17
Newspaper Article (8) 8
Book / eBook (4) 4
Conference Proceeding (3) 3
Magazine Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3152) 3152
index medicus (2534) 2534
oncology (2217) 2217
female (1894) 1894
cancer (1606) 1606
chemotherapy (1214) 1214
middle aged (1134) 1134
aged (983) 983
adult (888) 888
animals (856) 856
male (758) 758
ovarian cancer (734) 734
care and treatment (611) 611
advanced basic science (590) 590
pharmacology & pharmacy (573) 573
neoplasms - drug therapy (529) 529
survival (523) 523
antineoplastic combined chemotherapy protocols - therapeutic use (522) 522
carcinoma (516) 516
treatment outcome (516) 516
research (515) 515
advanced solid tumors (514) 514
obstetrics & gynecology (503) 503
cell lung-cancer (491) 491
antineoplastic agents - therapeutic use (482) 482
health aspects (468) 468
prognosis (462) 462
analysis (455) 455
tumors (449) 449
ovarian neoplasms - drug therapy (441) 441
cisplatin (439) 439
medicine & public health (435) 435
surgery (418) 418
neoplasm staging (413) 413
ovarian neoplasms - pathology (411) 411
advanced ovarian-cancer (409) 409
paclitaxel (375) 375
aged, 80 and over (362) 362
article (349) 349
metastasis (340) 340
ovarian-cancer (335) 335
hematology, oncology and palliative medicine (327) 327
advanced breast-cancer (317) 317
cell line, tumor (304) 304
advanced ovarian cancer (300) 300
mice (298) 298
breast-cancer (296) 296
retrospective studies (281) 281
neoadjuvant chemotherapy (280) 280
clinical trials (279) 279
phase-ii trial (279) 279
antineoplastic agents - pharmacology (278) 278
cell biology (270) 270
antineoplastic agents (260) 260
therapy (258) 258
ovarian neoplasms - surgery (252) 252
immunotherapy (249) 249
disease-free survival (248) 248
clinical trials as topic (246) 246
antimitotic agents (243) 243
cancer therapies (242) 242
drug therapy (242) 242
breast cancer (237) 237
phase-i (231) 231
antineoplastic combined chemotherapy protocols - adverse effects (230) 230
dentistry (230) 230
survival rate (229) 229
apoptosis (228) 228
antineoplastic agents - administration & dosage (224) 224
paclitaxel - administration & dosage (221) 221
trial (217) 217
medicine, research & experimental (216) 216
review (216) 216
hematology (213) 213
advanced cancer (211) 211
antineoplastic agents - adverse effects (205) 205
patients (202) 202
survival analysis (201) 201
phase-iii trial (200) 200
oncology, experimental (198) 198
advanced colorectal-cancer (197) 197
materials science, biomaterials (197) 197
medical research (195) 195
engineering, biomedical (194) 194
expression (193) 193
carboplatin (192) 192
biochemistry & molecular biology (188) 188
development and progression (187) 187
dose-response relationship, drug (187) 187
cytoreductive surgery (185) 185
cancer research (184) 184
gynecologic-oncology-group (184) 184
cisplatin - administration & dosage (182) 182
neoplasms - pathology (180) 180
phase-ii (178) 178
quality of life (178) 178
pharmacology/toxicology (177) 177
angiogenesis (176) 176
neoplasms - metabolism (172) 172
obstetrics and gynecology (169) 169
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4422) 4422
French (50) 50
German (21) 21
Spanish (10) 10
Japanese (9) 9
Polish (9) 9
Korean (6) 6
Russian (5) 5
Italian (3) 3
Czech (2) 2
Turkish (2) 2
Hungarian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 1/2018, Volume 81, Issue 1, pp. 17 - 38
Epithelial ovarian cancer is typically diagnosed at an advanced stage. Current state-of-the-art surgery and chemotherapy result in the high incidence of... 
Medicine & Public Health | Biological drugs | Targeted therapy | Clinical trials | Oncology | Cancer Research | Pharmacology/Toxicology | Ovarian cancer | ADVANCED EPITHELIAL OVARIAN | TRIFUNCTIONAL ANTIBODY CATUMAXOMAB | MALIGNANT ASCITES | PHASE-II | OPEN-LABEL | MAINTENANCE THERAPY | PLATINUM-RESISTANT | ONCOLOGY | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | PARP INHIBITORS | FOLATE RECEPTOR-ALPHA | ErbB Receptors - antagonists & inhibitors | Humans | Neoplasm Recurrence, Local - therapy | Precision Medicine - economics | Infusions, Parenteral | Neoplasm Recurrence, Local - drug therapy | Palliative Care | Antineoplastic Agents - therapeutic use | Clinical Trials as Topic | Antineoplastic Agents - administration & dosage | Cytoreduction Surgical Procedures | Poly(ADP-ribose) Polymerase Inhibitors - therapeutic use | Folic Acid Antagonists - therapeutic use | Cost-Benefit Analysis | Immunotherapy | Hyperthermia, Induced | Angiogenesis Inhibitors - therapeutic use | Ovarian Neoplasms - therapy | Receptors, Vascular Endothelial Growth Factor - antagonists & inhibitors | Female | Ovarian Neoplasms - drug therapy | Ovarian Neoplasms - surgery | Antimitotic agents | Chemotherapy | Chronic diseases | Antineoplastic agents | Health aspects | Sugars | Folic acid | Monosaccharides | Cancer | Drugs | Medical research | Ovarian carcinoma | Medical services | Poly(ADP-ribose) polymerase | Drug development | Cancer therapies | Disease control | Patients | Polymerase | Angiogenesis | Signaling | Inhibitors | Ribose | Surgery | Review
Journal Article
Nature Reviews Clinical Oncology, ISSN 1759-4774, 04/2016, Volume 13, Issue 4, pp. 255 - 261
Journal Article
Annals of Oncology, ISSN 0923-7534, 12/2013, Volume 24, Issue 10, pp. x7 - x15
Journal Article
Biomaterials, ISSN 0142-9612, 2011, Volume 32, Issue 23, pp. 5417 - 5426
Abstract Nanogels are comprised of swollen polymer networks and nearly 95% water and can entrap diverse chemical and biological agents for cancer therapy with... 
Advanced Basic Science | Dentistry | Folate-targeting | Drug delivery | Nanogel | Cisplatin | Ovarian cancer | MATERIALS SCIENCE, BIOMATERIALS | ENGINEERING, BIOMEDICAL | DOXORUBICIN | NANOCARRIERS | TOXICITY | ENDOCYTOSIS | FOLIC-ACID | STRATEGIES | MOLECULES | NANOPARTICLES | KB CELLS | LIPOSOMES | Doxorubicin - therapeutic use | Platinum - metabolism | Cisplatin - pharmacokinetics | Nanoparticles - chemistry | Humans | Ovarian Neoplasms - pathology | Body Weight - drug effects | Biological Availability | Polyethylene Glycols - chemistry | Antineoplastic Agents - therapeutic use | Doxorubicin - chemistry | Hydrogels - chemical synthesis | Antineoplastic Agents - administration & dosage | Cisplatin - administration & dosage | Cisplatin - chemistry | Osmolar Concentration | Light | Surface Properties | Water - chemistry | Inhibitory Concentration 50 | Microscopy, Atomic Force | Female | Antineoplastic Agents - pharmacokinetics | Antineoplastic Agents - pharmacology | Ovarian Neoplasms - metabolism | Scattering, Radiation | Ovarian Neoplasms - drug therapy | Doxorubicin - administration & dosage | Cell Survival - drug effects | Folic Acid - chemistry | Cisplatin - pharmacology | Polymethacrylic Acids - chemistry | Antineoplastic Agents - chemistry | Static Electricity | Doxorubicin - pharmacokinetics | Endocytosis - physiology | Particle Size | Xenograft Model Antitumor Assays | Animals | Cisplatin - therapeutic use | Mice, Nude | Survival Analysis | Cell Line, Tumor | Mice | Drug Delivery Systems - methods | Doxorubicin - pharmacology | Hydrogels - chemistry | Hydrogen-Ion Concentration | Anthracyclines | Polyethylene | Care and treatment | Biological products | Heterocyclic compounds | Polyelectrolytes | Ethylene oxide | Health aspects | Folic acid | Cancer
Journal Article
Hematology/Oncology Clinics of North America, ISSN 0889-8588, 12/2018, Volume 32, Issue 6, pp. 943 - 964
Journal Article
Current Opinion in Oncology, ISSN 1040-8746, 09/2014, Volume 26, Issue 5, pp. 521 - 528
Journal Article